Description
Dataset from the CounterCOVID study evaluating the efficacy of oral imatinib in hospitalised patients with COVID-19.
| Date made available | 2022 |
|---|---|
| Publisher | DANS Data Station Life Sciences |
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
- Erik Duijvelaar (Creator)
- E Duijvelaar (Contributor)
Dataset